Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2825248)

Published in Mol Cancer on February 04, 2010

Authors

Siyi Hu1, Nathalie Delorme, Zhenzhen Liu, Tao Liu, Cruz Velasco-Gonzalez, Jone Garai, Ashok Pullikuth, Shahriar Koochekpour

Author Affiliations

1: Stanley S Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Articles citing this

Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res (2012) 1.17

Sex-biased genetic effects on gene regulation in humans. Genome Res (2012) 1.05

A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J Neurosci (2012) 1.02

The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin. J Biol Chem (2014) 0.91

Androgen receptor mutations and polymorphisms in African American prostate cancer. Int J Biol Sci (2014) 0.87

Serum prosaposin levels are increased in patients with advanced prostate cancer. Prostate (2011) 0.86

Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells. PLoS One (2013) 0.85

Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon. Biol Med (Aligarh) (2014) 0.83

Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT. Int J Biol Sci (2014) 0.83

Androgen-responsive serum response factor target genes regulate prostate cancer cell migration. Carcinogenesis (2013) 0.82

REG4 promotes peritoneal metastasis of gastric cancer through GPR37. Oncotarget (2016) 0.78

New cathepsin D inhibitor library utilizing hydroxyethyl isosteres with cyclic tertiary amines. Med Chem (2012) 0.77

Analysis of the membrane proteome of ciprofloxacin-resistant macrophages by stable isotope labeling with amino acids in cell culture (SILAC). PLoS One (2013) 0.76

Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer. Breast Cancer Res (2015) 0.75

A p-Median approach for predicting drug response in tumour cells. BMC Bioinformatics (2014) 0.75

Total glucosides of paeony inhibits lipopolysaccharide-induced proliferation, migration and invasion in androgen insensitive prostate cancer cells. PLoS One (2017) 0.75

Articles cited by this

Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol (2008) 12.34

Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol (2006) 8.52

Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer (2004) 5.63

The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer (2005) 5.57

Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics (2005) 2.66

Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res (1996) 2.59

Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum Mol Genet (1996) 1.70

Saposins: structure, function, distribution, and molecular genetics. J Lipid Res (1992) 1.64

Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest (2005) 1.55

The MEK1 scaffolding protein MP1 regulates cell spreading by integrating PAK1 and Rho signals. Mol Cell Biol (2005) 1.34

Identification of prosaposin as a neurotrophic factor. Proc Natl Acad Sci U S A (1994) 1.25

Golgi fragmentation is associated with ceramide-induced cellular effects. Mol Biol Cell (2005) 1.21

Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur J Cancer (1997) 1.21

Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1. Proc Natl Acad Sci U S A (2009) 1.12

Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells. Mol Cancer Res (2006) 1.11

Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. Arch Biochem Biophys (1997) 1.10

Identification of the neurotrophic factor sequence of prosaposin. FASEB J (1995) 1.08

Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma. Am J Pathol (1996) 1.06

A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet (2001) 1.02

Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis. Glycobiology (2001) 1.01

Non-neuronopathic Gaucher disease due to saposin C deficiency. Clin Genet (2007) 1.01

Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis. J Proteome Res (2009) 1.00

Stimulation of acid ceramidase activity by saposin D. Arch Biochem Biophys (1994) 0.99

Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer (2005) 0.99

Intermolecular association of lysosomal protein precursors during biosynthesis. J Biol Chem (1994) 0.95

Prosaposin deficiency -- a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient. Neuropediatrics (2005) 0.94

Biosynthesis and intracellular targeting of the lysosomal aspartic proteinase cathepsin D. Adv Exp Med Biol (1998) 0.94

Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation. Biochem J (2004) 0.93

Quantification of integrin subunits on human prostatic cell lines--comparison of nontumorigenic and tumorigenic lines. Prostate (1997) 0.92

Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Mol Cancer (2004) 0.91

TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer. Breast Cancer Res Treat (2008) 0.90

Retracted Regulation of beta1C and beta1A integrin expression in prostate carcinoma cells. J Biol Chem (2003) 0.87

Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs. J Androl (2001) 0.86

Procathepsin D interacts with prosaposin in cancer cells but its internalization is not mediated by LDL receptor-related protein. Exp Cell Res (2002) 0.85

Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells. Asian J Androl (2005) 0.85

Secretion of prosaposin, a multifunctional protein, by breast cancer cells. Biochim Biophys Acta (1999) 0.85

Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells. Prostate (2004) 0.84

Three-dimensional type I collagen gel system containing MG-63 osteoblasts-like cells as a model for studying local bone reaction caused by metastatic cancer cells. Anticancer Res (1996) 0.82

Human cathepsin D precursor is associated with a 60 kDa glycosylated polypeptide. Biochem Biophys Res Commun (1992) 0.82

Role of cathepsin D in prostatic cancer cell growth and its regulation by brefeldin A. World J Urol (2001) 0.79

Prediction of the extent of prostate cancer by the combined use of systematic biopsy and serum level of cathepsin D. Int J Urol (2003) 0.78

Articles by these authors

Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63

Sequencing of 50 human exomes reveals adaptation to high altitude. Science (2010) 11.27

Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science (2010) 9.78

ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res (2012) 9.13

TreeFam: a curated database of phylogenetic trees of animal gene families. Nucleic Acids Res (2006) 8.83

Differential chromatin marking of introns and expressed exons by H3K36me3. Nat Genet (2009) 8.11

TreeFam: 2008 Update. Nucleic Acids Res (2007) 6.63

A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science (2011) 5.91

CEAS: cis-regulatory element annotation system. Bioinformatics (2009) 4.26

Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J Proteome Res (2005) 4.13

Repeated polyploidization of Gossypium genomes and the evolution of spinnable cotton fibres. Nature (2012) 4.00

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science (2012) 3.74

Identifying ChIP-seq enrichment using MACS. Nat Protoc (2012) 3.60

Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet (2012) 3.19

Moesin controls cortical rigidity, cell rounding, and spindle morphogenesis during mitosis. Curr Biol (2008) 2.92

Gait analysis using wearable sensors. Sensors (Basel) (2012) 2.90

Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst (2007) 2.77

Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics (2005) 2.50

Involvement of Lgl and Mahjong/VprBP in cell competition. PLoS Biol (2010) 2.45

Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics (2011) 2.44

Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics (2014) 2.37

The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. J Immunol (2011) 2.34

Systematic evaluation of factors influencing ChIP-seq fidelity. Nat Methods (2012) 2.31

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci U S A (2003) 2.31

Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14

Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics (2008) 2.08

Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression. Cancer Lett (2012) 2.05

Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? Clin Infect Dis (2007) 2.02

Head-to-head comparison of serum fractionation techniques. J Proteome Res (2007) 1.98

Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res (2005) 1.96

Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment. J Proteome Res (2006) 1.93

Practical guidelines for the comprehensive analysis of ChIP-seq data. PLoS Comput Biol (2013) 1.81

Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. J Natl Cancer Inst (2013) 1.78

Comparative RNAi screening identifies a conserved core metazoan actinome by phenotype. J Cell Biol (2011) 1.75

MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J (2009) 1.74

MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res (2003) 1.71

NONCODE v2.0: decoding the non-coding. Nucleic Acids Res (2007) 1.69

Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas (2007) 1.68

Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One (2011) 1.66

Using MACS to identify peaks from ChIP-Seq data. Curr Protoc Bioinformatics (2011) 1.64

A comprehensive view of nuclear receptor cancer cistromes. Cancer Res (2011) 1.64

Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res (2009) 1.58

Genome-wide map of nuclear protein degradation shows NCoR1 turnover as a key to mitochondrial gene regulation. Cell (2013) 1.55

Establishing the proteome of normal human cerebrospinal fluid. PLoS One (2010) 1.53

Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proc Natl Acad Sci U S A (2012) 1.52

Behavioral stress accelerates prostate cancer development in mice. J Clin Invest (2013) 1.52

Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models. Bioinformatics (2008) 1.51

Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya. J Low Genit Tract Dis (2012) 1.50

Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer (2010) 1.50

MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life (2009) 1.46

Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J Immunol (2010) 1.46

Mapping the C. elegans noncoding transcriptome with a whole-genome tiling microarray. Genome Res (2007) 1.46

Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet (2002) 1.46

Wnt5a enhances the response of CML cells to Imatinib Mesylate through JNK activation and γ-catenin inhibition. Leuk Res (2013) 1.43

Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol (2010) 1.42

SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet (2011) 1.41

Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. J Surg Res (2007) 1.40

A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1. Mol Cell Biol (2009) 1.39

Draft genome sequence of the mulberry tree Morus notabilis. Nat Commun (2013) 1.38

Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Crit Care (2014) 1.38

MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett (2012) 1.36

(E)-N-[4-(Methyl-sulfon-yl)benzyl-idene]aniline. Acta Crystallogr Sect E Struct Rep Online (2009) 1.36

China's health challenges. BMJ (2006) 1.36

Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol (2013) 1.34

The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res (2005) 1.32

Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano (2010) 1.31

Negative covariation between task-related responses in alpha/beta-band activity and BOLD in human sensorimotor cortex: an EEG and fMRI study of motor imagery and movements. Neuroimage (2009) 1.31

Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics (2012) 1.30

Liquid chromatography-mass spectrometry-based quantitative proteomics. J Biol Chem (2011) 1.30

Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature (2012) 1.30

Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncol Rep (2011) 1.30

(2E,6E)-2,6-Bis(4-ethoxy-benzyl-idene)cyclo-hexa-none. Acta Crystallogr Sect E Struct Rep Online (2008) 1.28

Potential challenges to the Stop TB Plan for humans in China; cattle maintain M. bovis and M. tuberculosis. Tuberculosis (Edinb) (2008) 1.26

Genetic variation of Chinese PRRSV strains based on ORF5 sequence. Biochem Genet (2006) 1.26

Genital tract leukocytes and shedding of genital HIV type 1 RNA. Clin Infect Dis (2008) 1.25

Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled "universal" reference sample. J Proteome Res (2009) 1.24

Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol (2011) 1.24

p53 targets identified by protein expression profiling. Proc Natl Acad Sci U S A (2007) 1.23

Differential effect of reward and punishment on procedural learning. J Neurosci (2009) 1.22

Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol (2007) 1.22

MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J (2010) 1.22

Broadband high photoresponse from pure monolayer graphene photodetector. Nat Commun (2013) 1.21

N200-speller using motion-onset visual response. Clin Neurophysiol (2009) 1.21

WAVE regulatory complex activation by cooperating GTPases Arf and Rac1. Proc Natl Acad Sci U S A (2011) 1.20

Spatial mapping of the neurite and soma proteomes reveals a functional Cdc42/Rac regulatory network. Proc Natl Acad Sci U S A (2008) 1.20

An unusual haplotype structure on human chromosome 8p23 derived from the inversion polymorphism. Hum Mutat (2008) 1.19

Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma. World J Gastroenterol (2008) 1.19

Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J (2008) 1.19

Persistence of side population cells with high drug efflux capacity in pancreatic cancer. World J Gastroenterol (2008) 1.18

Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One (2011) 1.18

Generation of new landomycins by combinatorial biosynthetic manipulation of the LndGT4 gene of the landomycin E cluster in S. globisporus. Chem Biol (2004) 1.17

Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol (2005) 1.16

Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy. World J Gastroenterol (2010) 1.16

Short-term effects of the 2008 cold spell on mortality in three subtropical cities in Guangdong Province, China. Environ Health Perspect (2012) 1.16

CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology (2012) 1.16

MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J (2012) 1.15

Organic phosphorus species in surface sediments of a large, shallow, eutrophic lake, Lake Taihu, China. Environ Pollut (2009) 1.14

miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) (2010) 1.13

Developmental dyslexia in Chinese and English populations: dissociating the effect of dyslexia from language differences. Brain (2010) 1.13